--- title: "12 Health Care Stocks Moving In Friday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/295960629.md" description: "On Friday, several healthcare stocks experienced significant intraday volatility. Gainers included MDxHealth (+120.8%), Capricor Therapeutics (+57.71%), and Akanda (+44.51%). Conversely, losers featured Dare Bioscience (-32.9%) and Healthcare Triangle (-28.04%). Many of these movements coincided with the release of Q2 or Q3 earnings reports." datetime: "2026-08-14T17:06:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295960629.md) - [en](https://longbridge.com/en/news/295960629.md) - [zh-HK](https://longbridge.com/zh-HK/news/295960629.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Friday's Intraday Session ### Gainers - **MDxHealth** (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular session. The company's market cap stands at $23.7 million. The company's, Q2 earnings came out yesterday. - **Capricor Therapeutics** (NASDAQ:CAPR) stock moved upwards by 57.71% to $6.64. The company's market cap stands at $243.8 million. As per the press release, Q2 earnings came out yesterday. - **Akanda** (NASDAQ:AKAN) shares moved upwards by 44.51% to $7.24. The company's market cap stands at $2.7 million. - **Eton Pharmaceuticals** (NASDAQ:ETON) stock increased by 39.14% to $56.77. The company's market cap stands at $1.1 billion. As per the news, the Q2 earnings report came out yesterday. - **HeartFlow** (NASDAQ:HTFL) shares increased by 33.26% to $41.33. The market value of their outstanding shares is at $2.6 billion. The company's, Q2 earnings came out yesterday. - **NeOnc Technologies Hldgs** (NASDAQ:NTHI) stock increased by 31.77% to $4.23. The market value of their outstanding shares is at $83.2 million. As per the news, the Q2 earnings report came out 4 days ago. ### Losers - **Dare Bioscience** (NASDAQ:DARE) shares decreased by 32.9% to $0.92 during Friday's regular session. The market value of their outstanding shares is at $20.5 million. The company's, Q2 earnings came out yesterday. - **Healthcare Triangle** (NASDAQ:HCTI) shares declined by 28.04% to $1.25. The market value of their outstanding shares is at $3.5 million. As per the press release, Q2 earnings came out yesterday. - **Outlook Therapeutics** (NASDAQ:OTLK) shares declined by 16.29% to $0.74. The market value of their outstanding shares is at $166.2 million. The company's, Q3 earnings came out today. - **PRF Technologies** (NASDAQ:PRFX) stock decreased by 15.42% to $1.01. The market value of their outstanding shares is at $3.6 million. - **Quoin Pharmaceuticals** (NASDAQ:QNRX) stock fell 15.29% to $5.12. The market value of their outstanding shares is at $12.1 million. The company's, Q2 earnings came out today. - **HeartBeam** (NASDAQ:BEAT) shares fell 15.09% to $0.5. The company's market cap stands at $32.7 million. As per the news, the Q2 earnings report came out yesterday. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [DARE.US](https://longbridge.com/en/quote/DARE.US.md) - [CAPR.US](https://longbridge.com/en/quote/CAPR.US.md) - [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md) - [MDXH.US](https://longbridge.com/en/quote/MDXH.US.md) - [HCTI.US](https://longbridge.com/en/quote/HCTI.US.md) - [ETON.US](https://longbridge.com/en/quote/ETON.US.md) - [HTFL.US](https://longbridge.com/en/quote/HTFL.US.md) - [NTHI.US](https://longbridge.com/en/quote/NTHI.US.md) - [OTLK.US](https://longbridge.com/en/quote/OTLK.US.md) - [PRFX.US](https://longbridge.com/en/quote/PRFX.US.md) - [QNRX.US](https://longbridge.com/en/quote/QNRX.US.md) - [BEAT.US](https://longbridge.com/en/quote/BEAT.US.md) - [74907L409.US](https://longbridge.com/en/quote/74907L409.US.md) - [BEATW.US](https://longbridge.com/en/quote/BEATW.US.md) ## Related News & Research - [Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders | CAPR Stock News](https://longbridge.com/en/news/296614024.md) - [Capricor Therapeutics (CAPR) Could Be 89% Undervalued Following Deramiocel And Loss Concerns](https://longbridge.com/en/news/296098763.md) - [Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit](https://longbridge.com/en/news/296500998.md) - [04:31 ETCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law](https://longbridge.com/en/news/296588659.md) - [Daré Bioscience DARE-HPV program advances with non-dilutive US government funding](https://longbridge.com/en/news/296233050.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**